Featured Research

from universities, journals, and other organizations

University Of Illinois At Chicago Chemists Synthesize Potent Anticancer Compound

Date:
November 10, 2000
Source:
University Of Illinois At Chicago
Summary:
An intricate molecule with exciting anticancer properties that is found only in minute amounts in a few species of South Pacific sponges has for the first time been synthesized in the laboratory by University of Illinois at Chicago chemists.

An intricate molecule with exciting anticancer properties that is found only in minute amounts in a few species of South Pacific sponges has for the first time been synthesized in the laboratory by UIC chemists. The 50-step, atom-by-atom assembly, reported in the Nov. 8 issue of the Journal of the American Chemical Society, not only means that scientists will have greater quantities of the rare molecule to study but also points the way to the synthesis of variants that may be even more medicinally useful.

The compound, laulimalide, named from the Hawaiian word laulima, "to work together," attacks cancer cells in a manner similar to the successful cancer drug Taxol but appears to be far more potent against tumors that have developed multiple-drug resistance. Discovered more than 10 years ago, laulimalide, which is chemically unrelated to Taxol, has been studied in several laboratories but is hard to come by, amounting to only one-tenth of 1 percent of a sponge's weight. It has also proven very difficult to make in the lab.

"The molecule is a most challenging one in its structural complexity," says Arun Ghosh, professor of chemistry at UIC. He and graduate student Yong Wang were racing as many as 10 top teams worldwide to synthesize the molecule, whose structure contains a 20-membered ring and nine asymmetric carbon atoms whose "handedness," or stereochemistry must be maintained.

"Building a molecule in a flask with all the bonds and specific configurations found in nature is as hard as building a space shuttle," Ghosh said. "We needed to preserve the stereochemistry at nine centers, maintain the cis configuration of six olefin bonds, and protect the epoxide and ester functions of the molecule."

Most exciting, Ghosh said, is that the stepwise synthesis allows for total control of the handedness of each of the nine asymmetric centers. "We now have the ability to invert each of them, and test each of those molecules for enhanced antitumor activity," he said, making a total of 512 possible variants.

Both Taxol and laulimalide work by disrupting the function of the cellular microtubules required for cell division, but laulimalide also inhibits the P-glycoprotein that is responsible for multiple-drug resistance in those tumor cells that possess it. Although laulimalide is only one-fifth as potent as Taxol in drug-sensitive laboratory cell lines, it is as much as 100 times more potent than Taxol in multi-drug-resistant cell lines.

The research reported in JACS was funded by the National Institute of General Medical Sciences, one of the National Institutes of Health.


Story Source:

The above story is based on materials provided by University Of Illinois At Chicago. Note: Materials may be edited for content and length.


Cite This Page:

University Of Illinois At Chicago. "University Of Illinois At Chicago Chemists Synthesize Potent Anticancer Compound." ScienceDaily. ScienceDaily, 10 November 2000. <www.sciencedaily.com/releases/2000/11/001110072735.htm>.
University Of Illinois At Chicago. (2000, November 10). University Of Illinois At Chicago Chemists Synthesize Potent Anticancer Compound. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2000/11/001110072735.htm
University Of Illinois At Chicago. "University Of Illinois At Chicago Chemists Synthesize Potent Anticancer Compound." ScienceDaily. www.sciencedaily.com/releases/2000/11/001110072735.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins